XPO1 inhibition by selinexor induces potent cytotoxicity against high grade bladder malignancies.

导出 OA

翻译打印收藏纠错

第一作者： Han Bit,Baek

第一单位： Veterans Affairs-Northern California Health Care System, Mather, CA, USA.

作者： Han Bit,Baek ^[1] ; Alan P,Lombard ^[2] ; Stephen J,Libertini ^[1] ; Aleida,Fernandez-Rubio ^[2] ; Ruth,Vinall ^[3] ; Regina,Gandour-Edwards ^[1] ; Rachel,Nakagawa ^[2] ; Kathleen,Vidallo ^[2] ; Kristine,Nishida ^[4] ; Salma,Siddiqui ^[5] ; Hiromi,Wettersten ^[2] ; Yosef,Landesman ^[2] ; Robert H,Weiss ^[2] ; Paramita M,Ghosh ^[1] ; Maria,Mudryj ^[6]

作者单位： Veterans Affairs-Northern California Health Care System, Mather, CA, USA. ^[1] Department of Medical Microbiology and Immunology, University of California Davis, Davis, CA, USA. ^[2] Biochemistry, Molecular, Cellular, and Developmental Biology Graduate Group and Biotechnology Program, University of California Davis, Davis, CA, USA. ^[3] California Northstate College of Pharmacy, Elk Grove, CA, USA. ^[4] Department of Pathology and Laboratory Medicine, University of California Davis, Sacramento, CA, USA. ^[5] Department of Internal Medicine, University of California Davis, Davis, CA, USA. ^[6] Karyopharm Therapeutics, Newton, MA, USA. ^[7] Department of Urology, University of California Davis, Sacramento, CA, USA. ^[8]

关键词 XPO1 bladder cancer cell cycle retinoblastoma selinexor

DOI 10.18632/oncotarget.26179

PMID 30349650

发布时间 2020-05-29

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交